Good morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and invigorating, because that all-too-familiar routine of meetings, deadlines, and what-not has returned. You knew this would happen, yes? To cope, we are quaffing a delicious cup of stimulation — peppermint mocha is now in our rotation — and invite you to join us, as always. Meanwhile, here are some tidbits to further stimulate you. Hope you have a smashing day and, of course, do keep in touch. We enjoy your furtive notes …

Nevada prison officials are refusing a demand by Pfizer (PFE) to return a drug and not use it in a planned lethal injection execution, the Associated Press reports. Plans for Nevada’s first execution in more than a decade — using a never-before-tried combination of diazepam, fentanyl, and the muscle paralytic cisatracurium — were put on hold last week pending review by the state Supreme Court.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • May I observe this phrasing is …. bemusing? “The regulator has already indicated that moving to Amsterdam, Barcelona, Copenhagen, Milan, or Vienna would cause the least disruption,…”
    And if Catalonia goes back on the independence route and leaves the EU? Then another move would be in the offing – one might strike Barcelona as a likely candidate, mighten one?

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy